576 related articles for article (PubMed ID: 25733077)
41. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity.
Maione F; Giglio MC; Luglio G; Rispo A; D'Armiento M; Manzo B; Cassese G; Schettino P; Gennarelli N; Siciliano S; D'Armiento FP; De Palma GD
Tech Coloproctol; 2017 Jul; 21(7):531-540. PubMed ID: 28674950
[TBL] [Abstract][Full Text] [Related]
42. Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience.
Santha SL; Shankar PR; Pan A; Schoen B; Kugathasan S; Sauer CG
Inflamm Bowel Dis; 2017 Aug; 23(8):1447-1453. PubMed ID: 28644180
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
Farkas K; Rutka M; Golovics PA; Végh Z; Lovász BD; Nyári T; Gecse KB; Kolar M; Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Malickova K; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Palatka K; Lakatos PL; Lukas M; Molnár T
J Crohns Colitis; 2016 Nov; 10(11):1273-1278. PubMed ID: 27106537
[TBL] [Abstract][Full Text] [Related]
44. Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients With Ulcerative Colitis.
Takenaka K; Ohtsuka K; Fujii T; Negi M; Suzuki K; Shimizu H; Oshima S; Akiyama S; Motobayashi M; Nagahori M; Saito E; Matsuoka K; Watanabe M
Gastroenterology; 2020 Jun; 158(8):2150-2157. PubMed ID: 32060000
[TBL] [Abstract][Full Text] [Related]
45. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
[TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
Mohammed N; Subramanian V
World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
[TBL] [Abstract][Full Text] [Related]
47. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study.
Fukuba N; Ishihara S; Tada Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kushiyama Y; Fujishiro H; Kinoshita Y
Scand J Gastroenterol; 2014 Jun; 49(6):674-80. PubMed ID: 24646420
[TBL] [Abstract][Full Text] [Related]
49. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis.
Kerur B; Litman HJ; Stern JB; Weber S; Lightdale JR; Rufo PA; Bousvaros A
World J Gastroenterol; 2017 May; 23(18):3322-3329. PubMed ID: 28566893
[TBL] [Abstract][Full Text] [Related]
50. Mucosal gene transcription of ulcerative colitis in endoscopic remission.
Arkteg CB; Goll R; Gundersen MD; Anderssen E; Fenton C; Florholmen J
Scand J Gastroenterol; 2020 Feb; 55(2):139-147. PubMed ID: 31918598
[No Abstract] [Full Text] [Related]
51. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
[TBL] [Abstract][Full Text] [Related]
52. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
Osterman MT; Scott FI; Fogt FF; Gilroy ED; Parrott S; Galanko J; Cross R; Moss A; Herfarth HH; Higgins PDR
Inflamm Bowel Dis; 2021 Jan; 27(2):207-214. PubMed ID: 32170946
[TBL] [Abstract][Full Text] [Related]
53. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
54. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission.
Feagins LA; Melton SD; Iqbal R; Dunbar KB; Spechler SJ
Inflamm Bowel Dis; 2013 Jun; 19(7):1477-82. PubMed ID: 23702713
[TBL] [Abstract][Full Text] [Related]
55. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study.
Giugliano FP; Strisciuglio C; Martinelli M; Andreozzi M; Cenni S; Campione S; D'Armiento M; Staiano A; Miele E
Dig Liver Dis; 2018 Mar; 50(3):240-246. PubMed ID: 29174208
[TBL] [Abstract][Full Text] [Related]
56. Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.
González-Partida I; Martínez-Lozano H; González-Lois C; Peligros I; Sánchez-Yuste R; Salas I; Matallana V; Bighelli F; Calvo M; Marín-Jiménez I; Salas C; Vera MI; Menchén L; González-Lama Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e796-e802. PubMed ID: 34334707
[TBL] [Abstract][Full Text] [Related]
57. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
[TBL] [Abstract][Full Text] [Related]
58. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
[TBL] [Abstract][Full Text] [Related]
59. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
[TBL] [Abstract][Full Text] [Related]
60. Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.
Theede K; Holck S; Ibsen P; Ladelund S; Nordgaard-Lassen I; Nielsen AM
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1929-36.e1. PubMed ID: 26051392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
